User profiles for Matan Levine-Tiefenbrun
 | Matan Levine-TiefenbrunTechnion- Israel Institute of Technology & Tel-Aviv University Verified email at mail.tau.ac.il Cited by 874 |
[HTML][HTML] Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
M Levine-Tiefenbrun, I Yelin, R Katz, E Herzel… - Nature medicine, 2021 - nature.com
Beyond their substantial protection of individual vaccinees, coronavirus disease 2019 (COVID-19)
vaccines might reduce viral load in breakthrough infection and thereby further …
vaccines might reduce viral load in breakthrough infection and thereby further …
[HTML][HTML] Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2
M Levine-Tiefenbrun, I Yelin, H Alapi, R Katz… - Nature medicine, 2021 - nature.com
The effectiveness of the coronavirus disease 2019 (COVID-19) BNT162b2 vaccine in preventing
disease and reducing viral loads of breakthrough infections (BTIs) has been decreasing…
disease and reducing viral loads of breakthrough infections (BTIs) has been decreasing…
[HTML][HTML] Waning of SARS-CoV-2 booster viral-load reduction effectiveness
M Levine-Tiefenbrun, I Yelin, H Alapi, E Herzel… - Nature …, 2022 - nature.com
The BNT162b2 COVID-19 vaccine has been shown to reduce viral load of breakthrough
infections (BTIs), an important factor affecting infectiousness. This viral-load protective effect has …
infections (BTIs), an important factor affecting infectiousness. This viral-load protective effect has …
Decreased SARS-CoV-2 viral load following vaccination
M Levine-Tiefenbrun, I Yelin, R Katz, E Herzel, Z Golan… - MedRxiv, 2021 - medrxiv.org
Beyond their substantial protection of individual vaccinees, it is hoped that the COVID-19
vaccines would reduce viral load in breakthrough infections thereby further suppress onward …
vaccines would reduce viral load in breakthrough infections thereby further suppress onward …
[HTML][HTML] SARS-CoV-2 RT-qPCR test detection rates are associated with patient age, sex, and time since diagnosis
M Levine-Tiefenbrun, I Yelin, H Uriel, J Kuint… - The Journal of Molecular …, 2022 - Elsevier
Quantifying the detection rate of the widely used quantitative RT-PCR (RT-qPCR) test for
severe acute respiratory syndrome coronavirus 2 and its dependence on patient demographic …
severe acute respiratory syndrome coronavirus 2 and its dependence on patient demographic …
Association of COVID-19 RT-qPCR test false-negative rate with patient age, sex and time since diagnosis
M Levine-Tiefenbrun, I Yelin, H Uriel, J Kuint… - medRxiv, 2020 - medrxiv.org
Background Routine testing for SARS-CoV-2 in the community is essential for guiding key
epidemiological decisions from the quarantine of individual patients to enrolling regional and …
epidemiological decisions from the quarantine of individual patients to enrolling regional and …
Association of COVID-19 RT-qPCR test false-negative rate with patient age, sex and time since diagnosis (preprint)
M Levine-Tiefenbrun, I Yelin, H Uriel, J Kuint… - 2020 - pesquisa.bvsalud.org
Background Routine testing for SARS-CoV-2 in the community is essential for guiding key
epidemiological decisions from the quarantine of individual patients to enrolling regional and …
epidemiological decisions from the quarantine of individual patients to enrolling regional and …
Waning of SARS-CoV-2 booster viral-load reduction effectiveness (preprint)
M Levine-Tiefenbrun, I Yelin, H Alapi, E Herzel, J Kuint… - 2021 - pesquisa.bvsalud.org
The BNT162b2 COVID-19 vaccine has been shown to reduce viral load of breakthrough
infections (BTIs), an important factor affecting infectiousness. This viral-load protective effect has …
infections (BTIs), an important factor affecting infectiousness. This viral-load protective effect has …
[CITATION][C] Decreased SARS-CoV-2 viral load following vaccination. medRxiv
M Levine-Tiefenbrun, I Yelin, R Katz, E Herzel, Z Golan… - Preprint posted online on …, 2021
[CITATION][C] Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine
M Levine-Tiefenbrun, I Yelin, H Alapi, R Katz, E Herzel… - medRxiv